We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.1%
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Industrials 11.84%
3 Consumer Discretionary 11.65%
4 Technology 10.61%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
51
United Therapeutics
UTHR
$21.9B
$35.2M 0.46%
271,965
+202,820
+293% +$26.1M
CAH icon
52
Cardinal Health
CAH
$55.2B
$35.1M 0.46%
435,351
+141,420
+48% +$11.2M
TYC
53
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$34M 0.45%
740,077
+734,825
+13,991% +$32.7M
AAPL icon
54
Apple
AAPL
$4.43T
$33.7M 0.44%
1,220,756
-1,476,192
-55% -$40.2M
LHO
55
DELISTED
LaSalle Hotel Properties
LHO
$33.4M 0.44%
+824,464
New +$31.7M
NKE icon
56
Nike
NKE
$63.3B
$32.8M 0.43%
681,812
-535,878
-44% -$25.1M
SPXC icon
57
SPX Corp
SPXC
$10.7B
$32.3M 0.43%
+1,494,704
New +$33.4M
LUV icon
58
Southwest Airlines
LUV
$23B
$31.2M 0.41%
+737,840
New +$27.5M
ETFC
59
DELISTED
E*Trade Financial Corporation
ETFC
$31.2M 0.41%
1,286,693
+50,642
+4% +$1.13M
TT icon
60
Trane Technologies
TT
$101B
$31.2M 0.41%
491,567
+79,338
+19% +$4.85M
CAT icon
61
Caterpillar
CAT
$382B
$30.6M 0.4%
+334,648
New +$32.6M
IFF icon
62
International Flavors & Fragrances
IFF
$20.6B
$30.5M 0.4%
300,535
-58,705
-16% -$5.8M
FMC icon
63
FMC
FMC
$1.3B
$30.2M 0.4%
610,708
-778,481
-56% -$38M
ALXN
64
DELISTED
Alexion Pharmaceuticals
ALXN
$29.9M 0.4%
161,762
-53,922
-25% -$9.99M
ROK icon
65
Rockwell Automation
ROK
$53.5B
$29.9M 0.39%
268,463
-257,465
-49% -$28.2M
WY icon
66
Weyerhaeuser
WY
$18.2B
$29.5M 0.39%
822,580
+640,990
+353% +$22M
FL
67
DELISTED
Foot Locker
FL
$29M 0.38%
515,400
+510,519
+10,459% +$28.3M
ORLY icon
68
O'Reilly Automotive
ORLY
$73.3B
$28.6M 0.38%
2,226,645
+1,576,035
+242% +$18.5M
PIR
69
DELISTED
Pier 1 Imports, Inc.
PIR
$28.5M 0.38%
+92,405
New +$24.6M
RGP
70
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$28.4M 0.38%
+1,184,032
New +$33.5M
VOYA icon
71
Voya Financial
VOYA
$9.07B
$28.2M 0.37%
664,932
+594,748
+847% +$23.8M
FLS icon
72
Flowserve
FLS
$9.78B
$27.9M 0.37%
+465,977
New +$29.6M
CAR icon
73
Avis
CAR
$4.91B
$27.7M 0.37%
417,896
-79,779
-16% -$4.56M
GILD icon
74
Gilead Sciences
GILD
$163B
$27M 0.36%
286,798
-153,969
-35% -$15.9M
PX
75
DELISTED
Praxair Inc
PX
$26.8M 0.35%
207,124
-288,049
-58% -$36.5M

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.